论文部分内容阅读
目的探讨灯盏花素注射液联合奥扎格雷钠治疗急性脑梗死(ACI)的临床疗效。方法将88例急性脑梗死患者随机分为两组,两组患者除给予常规治疗外,治疗组44例给奥扎格雷钠注射液80mg及灯盏花素注射液50mg,均1次/d;对照组44例给灯盏花素注射液50mg,1次/d。两组患者均治疗14d,观察治疗前后临床疗效和纤维蛋白原、凝血酶原时间等生化指标的变化并进行对比分析。结果治疗组显效率65.91%,对照组显效率47.73%,两组间基本痊愈率和显效率比较差异有统计学意义(P<0.05)。结论灯盏花素注射液联合奥扎格雷钠治疗急性脑梗死疗效肯定,能明显改善神经功能的损伤,不良反应少,是一种安全有效的方法。
Objective To investigate the clinical efficacy of breviscapine injection combined with ozagrel sodium in the treatment of acute cerebral infarction (ACI). Methods 88 patients with acute cerebral infarction were randomly divided into two groups. Except routine treatment, 44 patients in the treatment group received Ozagrel sodium injection 80mg and breviscapine injection 50mg once / d, while the control group Group 44 cases of breviscapine injection 50mg, 1 time / d. Two groups of patients were treated for 14 days, before and after treatment to observe the clinical efficacy and fibrinogen, prothrombin time and other biochemical indicators of change and comparative analysis. Results The effective rate was 65.91% in the treatment group and 47.73% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Breviscapine Injection combined with ozagrel sodium in the treatment of acute cerebral infarction is effective, can significantly improve the damage of neurological function, fewer adverse reactions, is a safe and effective method.